The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) closed at $7.21 in the last session, down -2.04% from day before closing price of $7.36. In other words, the price has decreased by -$2.04 from its previous closing price. On the day, 0.83 million shares were traded. AUPH stock price reached its highest trading level at $7.39 during the session, while it also had its lowest trading level at $7.21.
Ratios:
We take a closer look at AUPH’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.82 and its Current Ratio is at 5.33. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.19.
Oppenheimer Upgraded its Perform to Outperform on December 10, 2021, whereas the target price for the stock was revised from $33 to $31.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 06 ’24 when Habig Scott Michael sold 18,249 shares for $5.31 per share. The transaction valued at 96,902 led to the insider holds 456,338 shares of the business.
Balakrishnan Brinda sold 520 shares of AUPH for $2,985 on May 21 ’24. The Director now owns 17,523 shares after completing the transaction at $5.74 per share. On May 21 ’24, another insider, Billen Daniel, who serves as the Director of the company, sold 5,252 shares for $5.74 each. As a result, the insider received 30,146 and left with 28,141 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AUPH now has a Market Capitalization of 1030965184 and an Enterprise Value of 786614912. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.98 while its Price-to-Book (P/B) ratio in mrq is 2.83. Its current Enterprise Value per Revenue stands at 3.798 whereas that against EBITDA is -28.976.
Stock Price History:
Over the past 52 weeks, AUPH has reached a high of $10.05, while it has fallen to a 52-week low of $4.71. The 50-Day Moving Average of the stock is 2.82%, while the 200-Day Moving Average is calculated to be 18.80%.
Shares Statistics:
According to the various share statistics, AUPH traded on average about 1.25M shares per day over the past 3-months and 869790 shares per day over the past 10 days. A total of 143.83M shares are outstanding, with a floating share count of 128.68M. Insiders hold about 10.01% of the company’s shares, while institutions hold 40.37% stake in the company. Shares short for AUPH as of 1728950400 were 7189964 with a Short Ratio of 5.76, compared to 1726185600 on 7579493. Therefore, it implies a Short% of Shares Outstanding of 7189964 and a Short% of Float of 5.06.
